Ardent Health, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
9.23
-0.23 (-2.43%)
May 29, 2026, 4:00 PM EDT - Market closed
Ardent Health Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Ardent Health stock has a consensus rating of "Buy" and an average price target of $12.5. The average 1-year stock price forecast is 35.43% higher than the current stock price, while the lowest is $10 (+8.34%) and the highest is $14 (+51.68%).
Price Target: $12.5 (+35.43%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Ardent Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 6 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Maintains $15 → $14 | Buy | Maintains | $15 → $14 | +51.68% | May 15, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $13 | Buy | Maintains | $13 | +40.85% | May 7, 2026 |
| UBS | UBS | Buy Maintains $13 → $14 | Buy | Maintains | $13 → $14 | +46.26% | May 7, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $13 | Buy | Reiterates | $13 | +40.85% | May 6, 2026 |
Scott Fidel Goldman Sachs | Goldman Sachs | Hold Maintains $12 | Hold | Maintains | $12 | +30.01% | May 6, 2026 |
Financial Forecast
Revenue This Year
6.68B
from 6.32B
Increased by 5.69%
Revenue Next Year
6.99B
from 6.68B
Increased by 4.62%
EPS This Year
1.15
from 0.96
Increased by 19.66%
EPS Next Year
1.25
from 1.15
Increased by 9.20%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.9B | 7.3B | |
| Avg | 6.7B | 7.0B | |
| Low | 6.4B | 6.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.4% | 8.6% | |
| Avg | 5.7% | 4.6% | |
| Low | 0.8% | -1.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.28 | 1.56 | |
| Avg | 1.15 | 1.25 | |
| Low | 1.05 | 1.01 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 33.4% | 36.2% | |
| Avg | 19.7% | 9.2% | |
| Low | 9.2% | -12.1% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.